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Background: Approaches to increase organ availability for orthotopic liver transplantation (OLT) often
result in the procurement of marginal livers that are more susceptible to ischaemia, preservation and
reperfusion injury (IPRI).
Methods: The effects of post-OLT hyperbaric oxygen (HBO) therapy on IPRI in a syngeneic rat OLT
model were examined at various time-points. The effects of IPRI and HBO on hepatocyte necrosis,
apoptosis, proliferation, and sinusoidal morphology and ultrastructure were assessed.
Results: Post-OLT HBO therapy significantly reduced the severity of IPRI; both apoptosis [at 12 h: 6.4
 0.4% in controls vs. 1.6 0.7% in the HBO treatment group (p < 0.001); at 48 h: 2.4 0.2% in controls
vs. 0.4  0.1% in the HBO treatment group (p < 0.001)] and necrosis [at 12 h: 18.7  1.8% in controls vs.
2.4  0.4% in the HBO treatment group (p < 0.001); at 48 h: 8.5  1.3% in controls vs. 3.4  0.9% in the
HBO treatment group (P = 0.019)] were decreased. Serum alanine transaminase was reduced [at 12 h:
1068  920 IU/l in controls vs. 370  63 IU/l in the HBO treatment group (P = 0.030); at 48 h: 573 
261 IU/l in controls vs. 160  10 IU/l in the HBO treatment group (P = 0.029)]. Treatment with HBO also
promoted liver regeneration [proliferation at 12 h: 4.5  0.1% in controls vs. 1.0  0.3% in the HBO
treatment group (p < 0.001); at 48 h: 8.6  0.7% in controls vs. 2.9  0.2% in the HBO treatment group
(p < 0.01)] and improved sinusoidal diameter and microvascular density index.
Conclusions: Hyperbaric oxygen therapy has persistent positive effects post-OLT that may potentially
transfer into clinical practice.
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Introduction
Approximately 800 000 people die from end-stage liver disease
around the world each year.1 Orthotopic liver transplantation
(OLT) is widely accepted as the definitive treatment in end-stage
liver disease, selected liver malignancies and acute liver failure.
The major limitation of liver transplantation is the availability of
suitable donor organs. Increasing demand and rising mortality in
patients awaiting transplantation have led to a number of tech-
niques that increase the availability of donor organs.2–5 However,
these result in the procurement of organs with marginal func-
tional capacity.Marginal donor organs are more susceptible to the
effects of ischaemia, preservation and reperfusion injury (IPRI),
which leads to an increased incidence of dysfunction and organ
loss following transplantation.6
This paper is based on an oral presentation given at the Eighth World
Congress of the International Hepato-Pancreato-Biliary Association, 27
February to 2 March 2008, Mumbai.
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Ischaemia, preservation and reperfusion injury is a complex
process characterized by intracellular energy depletion leading to
activation of the innate immune system, which ultimately affects
parenchymal and non-parenchymal cells of the donor organ.7
Therapies targeting specific aspects of IPRI have been developed
and shown to ameliorate such injury in experimental8–11 and
some clinical12 settings. Their effects have been demonstrated
predominantly when applied prior to the onset of IPRI. Hyper-
baric oxygen (HBO) therapy is one such modality that appears
to simultaneously impact on multiple aspects of IPRI and to be
effective when applied after its onset.13 The majority of evidence
arises from in vitro studies and in vivo studies of warm
ischaemia–reperfusion injury. The effects of HBO in a more
realistic model of OLT, particularly in the presence of cold
preservation as seen in clinical liver transplantation, remain
unknown. This study investigates the impact of HBO therapy in
a rat model of OLT, when HBO treatment is delivered after the
onset of IPRI.
Materials and methods
In this study, irreversible hepatocyte injury was assessed according
to measurements of hepatocyte necrosis and apoptosis. Hepato-
cyte proliferation was measured as a potential surrogate marker of
injury. Liver biochemistry was analysed at the relevant time-
points. Changes in sinusoidal architecture and their relation to
hepatocyte injury were assessed with scanning electron micros-
copy (EM) analysis of microvascular resin casts. Effects on endot-
helial cell and hepatocyte morphology were determined using
transmission EM.
Animals and study design
Male Lewis rats (weighing 250–350 g; Laboratory Animal Ser-
vices, University of Adelaide, Adelaide, SA, Australia) were housed
in a temperature- and humidity-controlled room under a con-
stant 12 : 12 h light : dark cycle. Six animals were randomly
assigned to each group for this study. Four animals per group were
used for scanning EM analysis. Animals had free access to food
and water until surgery. All studies were conducted with the
approval of the Austin Animal Ethics Committee and in compli-
ance with the Australian Code of Practice for the Care and Use of
Animals for Scientific Purposes (2004).
The severity of IPRI (hepatocyte necrosis, apoptosis and pro-
liferation) was assessed in rat treatment and control groups. The
effects of HBO therapy were also investigated in normal rat liver.
In addition, animals underwent immediate OLT without a pres-
ervation period and were assessed at 48 h. Outcomes in this
group were compared with those in rats that underwent OLT
with 24-h preservation to investigate the effects of prolonged
preservation on IPRI. The temporal progression of liver injury
severity was investigated in animals receiving livers with a pres-
ervation time of 24 h and killed at specific endpoints of 6 h, 12 h,
24 h, 48 h and 7 days after OLT. The effects of IPRI and HBO
therapy on liver sinusoidal architecture were assessed by scanning
and transmission EM at 48 h after OLT. Treatment with HBO
began within 3 h of OLT as this regimen has been shown to
significantly reduce IPRI in a rat model.13 Rats in the HBO treat-
ment groups received two (12 h), three (24 h), five (48 h) or 15
(7 days) treatment sessions.
Donor hepatectomy and storage procedure
An orthotopic syngeneic liver transplant model with a 24-h period
of preservation in University of Wisconsin (UW) solution was
chosen as the model for IPRI in this study as it is highly repro-
ducible and features the same mechanisms and pathophysiology
as human liver transplantation. The donor hepatectomy proce-
dure has been described previously.14 Briefly, male Lewis rats were
anaesthetized with 1.5% isoflurane (David Bull Laboratories Pty
Ltd, Mulgrave, Vic, Australia) and continuous anaesthesia was
maintained using face masks. Laparotomy was undertaken, the
liver mobilized and the vascular system flushed with heparin prior
to perfusion with cold UW solution. Flushed livers were placed in
30 ml of UW solution at 4 °C and stored for 24 h at 4 °C prior to
transplantation.
Liver transplantation
Recipient rats were anaesthetized and subjected to midline lap-
arotomy. Recipient hepatectomy was performed and recipient
vessels prepared for transplantation. Donor livers were removed
from the preservation solution and OLT performed using an arte-
rialized technique previously described by Howden et al.14 The
anhepatic time during the transplantation procedure was limited
to <15 min in order to produce an extremely low mortality rate
despite the severity of liver injury.15
Administration of HBO therapy
Rats were recovered from anaesthesia and transferred to the
HBO chamber within 3 h of liver reperfusion. Treatment with
HBO was continued twice daily at 12-h intervals until the
selected endpoints. Each treatment session (153 kPa with 100%
oxygen) was delivered for 90 min, which is the standard
treatment time adopted for rodent experiments by this study
group.16
Collection of liver samples
The study endpoints were defined as 12 h, 24 h and 48 h after
reperfusion. Rats were anaesthetized with an intraperitoneal
injection of 400 ml ketamine (100 mg/kg) (Pfizer Australia, West
Ryde, NSW, Australia) and xylazine (10 mg/kg) [Troy Laborato-
ries (Australia) Pty Ltd, Glendenning, NSW, Australia]. The liver
was removed from the anaesthetized rat, weighed and fixed in
10% buffered formalin (Sigma-Aldrich Corp., St Louis, MO,
USA). Because of the hepatic anatomy and the variable sizes of the
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rat liver lobes, which may influence the degree of IPRI, each liver
was divided into three parts for assessment: the median, left and
right lobes.
Assessment of hepatic necrosis
After 48 h of fixation, livers were preserved in 50% ethanol and
each lobe was sliced into 1.5-mm-thick sections using a multi-
blade fractionator. Two random slices from each liver lobe (right,
median and left) were processed for paraffin blocks and stained
with haematoxylin and eosin. Images from each section of liver
were captured using a randomized pattern to ensure that the areas
captured were representative of the entire tissue slice. Each image
was then analysed to determine the area of necrosis using an
image analysis program (Image Pro Plus®; CyberMedia, Perth,
WA, Australia), in which the areas of necrosis and subsequently
the total liver areas were traced electronically. The areas were used
to calculate the percentage of necrosis as a function of the total
liver area and were determined for each lobe for all livers. The
mean percentage of necrosis in each liver lobe was expressed as the
mean  standard error of the mean (SEM) and was used to
indicate the extent of IPRI in the control and treatment groups.
This method has been previously validated by this study group
and the levels of injury shown in the individual lobes are consid-
ered to be representative of an entire rat liver in this model.16,17
Immunohistochemistry
Paraffin-embedded liver tissue sections (4 mm) were stained with
monoclonal antibodies using an indirect polymer immunoper-
oxidase technique. The tissues were stained for proliferating cells
(Ki67) and apoptotic cells (active caspase-3; Sapphire Bioscience
Pty Ltd, Waterloo, NSW, Australia). One random slice from each
of the three liver lobes (right, median and left) in each rat was
stained. Specific binding of primary antibodies was detected
using a polymer detection system for either rabbit or mouse
primary antibodies. (DAKO Envision Plus; Dako Australia Pty
Ltd, Botany, NSW, Australia) using standard procedures. The
reaction was developed using 3,3-diaminobenzidine tetrachlo-
ride (Sigma-Aldrich Australia Pty Ltd, Castle Hill, NSW,
Australia) and hydrogen peroxide (H2O2), counterstained with
Mayer’s haematoxylin (Sigma-Aldrich Australia Pty Ltd),
dehydrated, and mounted in DPX mountant (Merck Pty Ltd,
Kilsyth, Vic, Australia).
Quantitative assessment of immunohistochemical
staining
Staining of proliferating hepatocytes and apoptotic cells was
analysed using Image Pro Plus®. In these analyses, the observer
was blinded to the treatment group. Twelve random, non-
overlapping images from each liver lobe were captured at ¥50
magnification for each slice. Quantitation of stained cells was
performed by identifying and counting positively stained cells.
Non-stained cells were also counted. Counts were expressed as
percentages of the total number of hepatocytes determined for
each lobe for all livers. The percentage of proliferating or apop-
totic cells in each liver lobe was expressed as the mean  SEM
and used to compare findings in control and treatment
groups.
Liver biochemistry
Blood was collected at the respective endpoints by cardiac punc-
ture to produce serum samples. Minimum quantities of 160 ml of
serum from each sample were placed in separate microcentrifuge
tubes and stored at -20 °C. The samples were analysed for liver
biochemistry [bilirubin, alanine transaminase (ALT), alkaline
phosphatase (ALP), g-glutamyl transferase (GGT)] using a timed
endpoint Diazo method, an enzymatic rate method and a kinetic
rate method to measure the levels of the respective factors
(Department of Anatomical Pathology, Austin Health, Mel-
bourne, Vic, Australia).
Microvascular resin casting and scanning EM analysis
Microvascular resin casting was undertaken as previously
described.18 Briefly, left thoracotomy was performed in anaesthe-
tized rats and the left lung mobilized to the right to expose the
thoracic aorta. A catheter was inserted caudally into the thoracic
aorta to flush the circulation with a mixture of warm (37 °C)
saline solution (0.9% NaCl), 60 mg/l polyvinyinyl-pyrolidone,
heparin (10 units/ml) and papaverine (0.25 ml/l) (at a constant
pressure of 120 mmHg) and vented through an incision in the
heart.When the effluent was clear (approximately 100 ml of saline
infusion), the pressure was released. A resin mixture was then
infused (at a pressure of 160 mmHg). The resin was allowed to
polymerize in situ overnight and the liver carefully removed.
Organic tissue was dissolved using several changes of 20% potas-
sium hydroxide (KOH). The resulting resin casts were rinsed to
remove debris, and frozen in milliQ water to enable the casts to be
cut into smaller pieces using a hand electric rotary saw (Dremel
Moto Tool Co., Racine,WI,USA). The casts were then prepared by
standard methods for scanning EM.18 Each cast was examined
under scanning EM and images of randomly selected areas were
captured in order to obtain measurements of sinusoidal diameters
and microvascular index.
Measuring sinusoidal diameters
Analysis of the microvascular images captured using scanning EM
was conducted using an image analysis program (Image Pro
Plus®). Images were calibrated for assessment using the magnifi-
cation bar on each image. A grid mask was then placed over the
image and the largest vessel in each grid was measured using a
drag line. Analysis was performed by measuring 20 sinusoidal
diameters from images at ¥1000 magnification. Sixteen images
from each liver were analysed and data expressed as the mean 
standard deviation (SD) for each group. Sinusoidal diameters
were measured only in regions without large empty spaces corre-
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sponding to areas of coagulative necrosis to represent the
microvascular changes occurring in the surviving viable regions of
the liver.
Assessing changes to the microvascular
density index
Themicrovascular density index (MDI) was measured using scan-
ning EM images (¥1000 magnification) of resin casts from rats in
the control and treatment groups at 48 h after transplantation.
Images were captured in locations where no physical damage was
present and the lobular architecture was maintained. Image Pro
Plus® was used to apply a colour mask to the area occupied by all
the vessels in the foreground of each image. A measuring tool was
used to determine the area occupied by vascular structures and the
MDI was calculated as the percentage of the area of vascular
structures divided by the area of image sampled. Individual MDIs
were used to determine the mean MDI in each treatment group.19
Transmission EM
Tissue samples from the left liver lobe were collected from the
control and HBO treatment groups at 48 h after OLT and imme-
diately cut into 1-mm3 pieces and fixed in 2.5% gluteraldehyde in
phosphate buffer overnight prior to being placed in phosphate
buffered saline. Transmission EM was performed on these tissues
after the routine preparation of sections using standard tech-
niques to obtain a descriptive analysis of the cellular morphologi-
cal changes seen in liver transplantation and HBO treatment.
Statistical analysis
All data (including graphical representations) are expressed as the
mean SEM unless otherwise stated. Statistical analysis was con-
ducted in spss Version 13.0 (SPSS, Inc., Chicago, IL, USA) using
both parametric and non-parametric tests as appropriate in nor-
mality testing. Animal numbers were based on previous studies
conducted by this group and were calculated to achieve 95% con-
fidence with a power of 0.8. Data were tested for normality using
descriptive statistics such as skewedness and kurtosis of the data,
detrended normal Q–Q plots and the Kolgomorov–Smirnov test.
An analysis of variance (anova) was performed for normally
distributed data and post hoc analysis was performed if signifi-
cance was determined [least significant difference (LSD) or Schef-
fe’s procedure]. Kruskal–Wallis followed by Mann–Whitney rank
sum tests were used to analyse data that were not normally dis-
tributed. A P-value of 0.05 was deemed to indicate statistical
significance in all analyses.
Results
Effects of HBO therapy on normal liver
Livers from normal rats were compared with livers from animals
exposed to two doses of HBO therapy and differences in hepato-
cyte necrosis, apoptosis and proliferation were analysed. Neither
normal livers nor HBO-treated livers demonstrated any measur-
able evidence of coagulative necrosis. The baseline rate of hepa-
tocyte apoptosis in normal livers was low in all lobes (left, median
and right lobes) and was not altered by HBO therapy (0.1 0.0%
vs. 0.1  0.0%; p > 0.05) (Fig. S1, online). Baseline hepatocyte
proliferation in all three normal liver lobes assessed was
unchanged by HBO therapy (0.9 0.2% vs. 1.2 0.2%; p > 0.05)
(Fig. S2, online).
Effects of prolonged preservation on IPRI severity
Outcomes in rats that underwent immediate OLT with minimal
cold preservation were compared with those in rats that under-
went OLT using donor organs preserved for 24 h (Fig. 1a). Rats in
both groups were killed 48 h after OLT and the severity of IPRI
assessed by comparing hepatocyte necrosis, apoptosis and cell
proliferation. Prolonged cold preservation resulted in significantly
greater hepatocyte necrosis, apoptosis and proliferation compared
with minimal cold preservation (p < 0.001) (Fig. 1a). These dif-
ferences were similar across individual lobes (data not shown).
Effects of IPRI on development of hepatocyte
necrosis, apoptosis and proliferation
Prolonged organ preservation and subsequent OLT produced
severe IPRI (Fig. 1b, Fig. S3). Coagulative hepatocyte necrosis was
apparent at 6 h after reperfusion, peaked at 12 h and slowly
declined to 24 h and 48 h (Fig. 1b). Necrosis was no longer
evident by day 7. Hepatocyte apoptosis followed a similar pattern,
increasing rapidly to 6 h, peaking at 12 h and declining to baseline
levels by day 7. Hepatocyte proliferation in response to IPRI
increased slowly, peaked at 48 h and remained elevated until day 7.
Effects of HBO therapy on hepatocyte necrosis in the
left, median and right liver lobes
Coagulative necrosis in the individual lobes of control livers
showed that the left lobe developed a significantly greater
degree of necrosis at 12 h compared with the median (p < 0.001)
and right (p < 0.001) lobes (Fig. S4). Similar patterns were
seen at both 24 h and 48 h. Therapy with HBO significantly
decreased the development of hepatocyte necrosis at all
time-points (Fig. 2). The difference was most marked at 12 h
(p < 0.001), but remained significant at 24 h and 48 h (p < 0.001
and p < 0.05, respectively). The effects were statistically signifi-
cant in each individual lobe at these time-points except in the
right lobe at 24 h and the left lobe at 48 h, when they
approached but did not reach significance (Fig. S4). At 7 days
after OLT, necrosis was no longer evident in either the control or
treatment groups.
Effects of HBO therapy on hepatocyte apoptosis in
the left, median and right liver lobes
The percentage of hepatocytes undergoing apoptosis demon-
strated a 60-fold increase from a baseline normal value of 0.10 
0.0% by 12 h (p < 0.001) (Fig. 2), which progressively reduced at
the 24-h and 48-h time-points. The left lobe developed a higher
rate of apoptosis than the median and right lobes (Fig. S4). The
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rate of apoptosis in HBO-treated animals increased slightly but
significantly at 12 h compared with normal liver (p < 0.001) and
was found to progressively reduce at 24 h and 48 h after OLT
(p < 0.001 and p < 0.001, respectively) (Fig. 2). This difference
was also reflected in the individual lobes at each time-point
(Fig. S4). At day 7 after OLT, the rate of apoptosis had signifi-
cantly reduced to similar levels in both the control and treat-
ment groups.
Effects of HBO therapy on hepatocyte proliferation in
the left, median and right liver lobes
The rate of hepatocyte proliferation following OLT remained
unchanged at 6 h and 12 h compared with normal liver (P = 0.7).
However, by 24 h, a progressive but significant increase became
apparent and remained at 48 h (p < 0.05) (Fig. 2). Individual lobes
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Figure 1 (a) Effects of prolonged preservation on the severity of
ischaemia, preservation and reperfusion injury (IPRI) assessed by
necrosis, apoptosis and proliferation at 48 h post-orthotopic liver
transplantation (OLT). Preservation times 0 (n = 3) vs. 24 h (n = 6).
Transplantation after prolonged cold storage of 24 h resulted in
significantly greater hepatocyte necrosis, apoptosis and proliferation
than immediate transplantation [8.5  1.3% vs. 0.8  0.5% (p <
0.001), 2.4  0.2% vs. 0.4  0.1% (p < 0.001) and 8.6  0.7% vs.
2.9  0.2% (p < 0.001), respectively]. This also demonstrated that
the proliferation index is a surrogate marker of hepatocyte injury.
Error bars represent the standard error of the mean (SEM). (b) Tem-
poral changes of IPRI in hepatocyte necrosis, apoptosis and prolif-
eration in control livers at 6 h (n = 6), 12 h (n = 6), 24 h (n = 3), 48 h
(n = 6) and 7 days (n = 6). Hepatocyte necrosis and apoptosis
increased rapidly to peak at 12 h after OLT and progressively nor-
malized by day 7. The hepatocyte proliferation index did not
increase until 24 h and continued to do so to 48 h. At 7 days, it had
reduced but remained higher than normal. Error bars represent the
SEM
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Figure 2 Effects of hyperbaric oxygen (HBO) therapy on hepatocyte
necrosis, apoptosis and proliferation. Progression line charts collate
total hepatocyte necrosis, apoptosis and proliferation across the
four time-points of 12 h, 24 h, 48 h and 7 days. Treatment with HBO
significantly reduced necrosis and apoptosis at all time-points and
significantly increased hepatocyte proliferation at all time-points
except at day 7, when it had returned to normal levels. Data are
expressed as the percentage area occupied by necrosis, the per-
centage of apoptotic cells, and the percentage of hepatocytes pro-
liferating. All HBO-treated groups: n = 6. Error bars represent the
standard error of the mean. *p < 0.05; †p < 0.001
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demonstrated similar patterns of proliferation at each time-point
(Fig. S4). Therapy with HBO resulted in a rapid increase in hepa-
tocyte proliferation. This was significantly increased as early as
12 h and continued to increase rapidly at 24 h and 48 h (p <
0.001). At day 7, hepatocyte proliferation remained significantly
elevated in control rats but had returned to normal levels in HBO-
treated rats (p < 0.001).
Changes in liver biochemistry with IPRI
and HBO therapy
Alterations in serumALT occurred early after OLT in IPRI control
rats. Serum ALT increased significantly at 6 h and peaked at 12 h
(1068  920 IU/l) after OLT, declining to normal levels at day 7
(Fig. 3). Therapy with HBO significantly attenuated the ALT rise
at the 12-h, 24-h and 48-h time-points (P = 0.03). By contrast,
serum bilirubin, ALP and GGT were minimally elevated at the
24-h time-point, but rose rapidly to 48 h in the IPRI controls. In
the HBO treatment group, serum bilirubin, ALP and GGT levels
were found to be slightly higher than in controls in the first 24 h,
but reduced significantly at 48 h for ALP (P = 0.03) and GGT (P =
0.03). Serum bilirubin reduced from 45.0  19.0 mmol/l in con-
trols to 8.0  2.6 mmol/l with HBO treatment over this period;
however, sample variation did not allow statistical significance to
emerge (P = 0.1).
Scanning EM features of liver sinusoids after IPRI and
HBO treatment
Scanning EM images of resin casts from livers of normal rats
demonstrated the complete filling of sinusoids organized in a
typical hepatic lobular arrangement. At low magnification
(¥200), cross-sections of vascular casts revealed hepatic
sinusoids radiating from the portal venous branches within
portal triads and converging towards the central venules
(Fig. 4a). At higher magnification (¥1000), sinusoids were
densely arranged, complete and had multiple branches
(Fig. 4d).
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Figure 3 Effects of hyperbaric oxygen (HBO) therapy on liver biochemistry. Serum alanine transaminase (ALT) levels peaked at 12 h and
progressively reduced. Therapy with HBO significantly reduced the rise in ALT at all time-points. Serum bilirubin, alkaline phosphatase (ALP)
and g-glutamyl transferase (GGT) followed a common trend, demonstrating an increase only at 48 h. Therapy with HBO significantly reduced
this rise at the 48-h time-point. All levels had normalized by day 7 (data not shown). Error bars represent the standard error of the mean.
*p = 0.03
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Figure 4 Effects of hyperbaric oxygen (HBO) therapy on liver microvasculature. (a–f) Scanning electron microscopy images of microvascular
casts from normal rat liver at (a, d) baseline, (b, e) 48 h after orthotopic liver transplantation (OLT) and (c, f) 48 h after OLT with HBO therapy.
The architecture in the normal liver is seen to be significantly disrupted in the OLT control group (b, e). Reductions in diameter, blind-ended
sinusoids and extravasation of casting material indicate microvascular disruption. Therapy with HBO maintained normal structure and
prevented disruptive changes. S, liver sinusoids; CV, central vein; P, portal triad; white arrows, absence of filling showing blockage; B,
blind-ended vessels; E, extravasated casting material. [Original magnification: (a–c) ¥150, (d–f) ¥1000.] (g, h) Effects of HBO on sinusoidal
diameter and microvascular density index. The OLT control livers demonstrated a significant reduction in mean sinusoidal diameter (8.9 
0.9 mm vs. 10.8 0.2 mm; p < 0.01) and density index (percentage of vascularity) (68.6 1.0% vs. 59.9 1.4%; p < 0.001) at 48 h compared
with normal livers. Therapy with HBO prevented these changes in mean sinusoidal diameter (10.3 0.1 mm vs. 10.8 0.2 mm; p > 0.05) and
density index (68.6  1.0% vs. 68.8  0.9%; p > 0.05) compared with normal liver. All groups: n = 4; 16 images at each time-point for each
liver. Error bars represent the standard error of the mean
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Control rat livers at 48 h demonstrated areas of incomplete
filling, particularly in perivenular regions of the hepatic lobule
(Fig. 4b). Sinusoids were seen to end blindly, suggesting microvas-
cular occlusion. An obvious and typical feature was a reduction in
vessel density represented by clusters of discontinuous and blind-
ended sinusoids (Fig. 4e). Analysis of multiple scanning EM fields
at low magnification (¥125) revealed areas lacking in microvascu-
lar filling, indicative of necrosis (Fig. 4b).
Exposure to HBO therapy appeared to prevent these changes.
Although HBO reduced sinusoidal density, sinusoids remained
patent and continuous. On low-power imaging, it was not
possible to differentiate between images from normal and
HBO-treated animals (Fig. 4a, c). Rat livers treated with HBO
demonstrated intact microvascular architecture (Fig. 4f) charac-
terized by patent and dense sinusoids (Fig. 4c, f). Cross-sections of
resin casts showed normal hepatic architecture with no areas of
unfilled vessels or extravasation of casting material, and vessels
were seen to radiate towards the portal vein, as in control livers.
Effects of IPRI and HBO therapy on
microvascular diameter
The mean diameter of liver sinusoids in normal rat liver was 10.8
 0.2 mm. This decreased significantly at 24 h after OLT and even
further by 48 h (p < 0.01). The effect of HBO therapy in IPRI on
sinusoidal diameter assessed at the 48-h time-point showed that
HBO therapy prevented the decrease in microvascular diameter so
that no significant difference in this parameter emerged in a com-
parison with normal rat liver (p > 0.05). At the 48-h time-point,
sinusoidal vessels in HBO-treated livers were significantly greater
in diameter than those in controls (p < 0.05) (Fig. 4g).
Effects of IPRI and HBO therapy on MDI
The mean MDI of normal rat liver was determined to be 68.6 
1.0%. At 48 h post-OLT, mean MDI was markedly reduced (p <
0.001) (Fig. 4h). Treatment with HBO reversed the reduction in
MDI after OLT so that mean MDI in HBO-treated rat liver was
found to mirror that in normal liver.
Transmission EM of liver sinusoids and effects of IPRI
and HBO treatment
In normal rat livers, hepatocytes with distinct intracellular
organelles were seen. Sinusoidal endothelial cells were seen to have
clear margins and thin cytoplasm with normal nuclear morphol-
ogy (Fig. 5a). At high magnification, endothelial fenestrae were
present and were visualized as discontinuous pores.Mitochondria
and rough endoplasmic reticulum were seen. Red blood cells were
seen traversing the sinusoidal spaces.
At 48 h post-transplantation, significant ultrastructural
changes were visible. The general architecture of the hepatic
lobules was somewhat retained, although a range of degenerative
changes were apparent. The hepatocyte microvilli were reduced in
number and completely absent in some areas. Extensive vacu-
olization within hepatocytes was also widely seen. Lysosomes were
more abundant than in normal hepatocytes. Mitochondria were
often swollen, rounded and surrounded by fragmented rough
endoplasmic reticulum (Fig. 5b). Changes in endothelial cells
were heterogeneous. Many endothelial cells appeared swollen and
detached, and were located within the sinusoidal lumen. Widen-
ing of the endothelial fenestrae was also more prominent
(Fig. 5b).
Liver tissues from HBO-treated OLT rats demonstrated evi-
dence of improvement in cellular architecture and ultrastructure
compared with control livers. The lobular arrangement of hepa-
tocytes was well preserved and showed little evidence of vacuoles.
However, hepatocytes contained an increased number of lysos-
omes. The mitochondria displayed reduced swelling and the
rough endoplasmic reticulum was more organized than that seen
(a) (b) (c)
Figure 5 Effects of hyperbaric oxygen (HBO) on endothelial cell and hepatocyte ultrastructure. Transmission electron microscopy images of
normal liver, 48 h after orthotopic liver transplantation (OLT) and 48 h after OLT with HBO therapy. (a) Normal liver demonstrates clear
intracellular organelles (O). The attachment of liver sinusoidal endothelial cells (LSECs) to hepatocytes is smooth (arrow). Mitochondrial (M)
and smooth endoplasmic reticular (sER) structures remain normal. (b) At 48 h after OLT, significant cellular disruption is seen with
detachment of LSECs (white arrow) and disruption of intracellular organelles (O). (c) These changes are reversed in the HBO treatment group,
in which LSECs and hepatocytes show a more normal liver-like appearance. (Original magnification ¥6675)
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in controls. Normal morphological nuclear structure was also
observed. Microvilli extending from the hepatocytes into the
space of Disse were present, although absent from some areas. The
majority of endothelial cells retained normal ultrastructure,
although some remained swollen. By contrast with the control
group, no endothelial cells were seen to be detached or lying
within the sinusoidal lumen and their long elongated nuclei were
seen to spread along the length of the sinusoid (Fig. 5c). Some
discontinuity along the sinusoidal lining and widening of fenes-
trae were apparent, but the severity of these changes appeared to
be significantly less than in the control group.
Discussion
Orthotopic liver transplantation is the only potentially curative
therapy in end-stage liver disease, selected liver malignancies and
fulminant hepatic failure. Rising demand for OLT has resulted in
an increase in the use of donor organs in which functional capac-
ity is reduced for a variety of reasons. These marginal donor
organs appear to be more susceptible to post-OLT dysfunction.20
The major contributor to post-OLT organ dysfunction is IPRI.
The implementation of viable therapeutic strategies to minimize
IPRI would not only improve outcomes of OLT, but might poten-
tially increase the safety of using marginal donor organs.
Ischaemia, preservation and reperfusion injury is a complex
process involving interactions among a wide variety of donor and
recipient cell types, including hepatic parenchymal and non-
parenchymal cells and constituents of the innate and adaptive
immune systems. A number of targeted therapies have demon-
strated amelioration of IPRI in mostly animal8–11 and some clini-
cal12 studies. The majority of in vivo animal studies evaluating
these therapies used a warm ischaemia–reperfusion model. These
are supplemented by in vitro studies mimicking similar conditions
by providing an environment of hypoxia and hypoglycaemia.21
However, these therapies generally target only one component of
this complex process and usually require application prior to the
onset of IPRI. Inhibition of Kupffer cells by glycine or gadolinium
chloride,9,22 neutrophil depletion,10 cell surface receptor blockade
(ICAM-1, CD11/18), inhibition of inflammatory cytokines,23
regulation of complement activation,24 anti-oxidants, delivery of
exogenous or endogenous adenosine and alteration of the endot-
helial nitric oxide (NO) balance8 have been shown to improve
IPRI. By contrast, HBO treatment has been shown to simulta-
neously interact with multiple components of this process.
Therapy with HBO can reduce the expression of ICAM-1 in
injured endothelial cells,25 inhibit expression of CD11/18 on neu-
trophils,26 reduce neutrophil sequestration,27 improve micro-
circulation,19 reduce tumour necrosis factor-a (TNF-a) and
interleukin-1 (IL-1) levels28 and modulate the production and
effects of reactive oxygen species leading to increases in various
anti-oxidant functions.
Significantly, a number of studies have demonstrated that HBO
therapy delivered early after the onset of IPRI continues to influ-
ence its severity.13 Treatment with HBO administered within 3 h
of onset of warm IPRI significantly reduces IPRI in a rat model13
and hence this time-point was chosen for the present study. The
present series of experiments employed a model of OLT that pro-
duces severe IPRI with sequential warm ischaemia, cold preserva-
tion and warm reperfusion and is representative of conditions in
human OLT. These experiments demonstrate the efficacy of HBO
therapy in reducing IPRI in an animal model that closely
reproduces the pathophysiological changes that occur in clinical
transplantation.
Despite the importance of evaluating the degree of liver injury
after OLT, the assessment of severity of IPRI remains an inexact
science. The most common techniques used to quantify IPRI are
liver biochemistry,29 bile production, cytokine release from tissue
injury, histopathological scoring systems30 and overall survival.
This study used hepatocyte cell death, indicated by necrosis and
apoptosis, as a marker of the severity of IPRI. A quantitative
stereological technique was applied to areas of necrosis to allow
objective measurements in preference to the commonly used sub-
jective histopathological scoring systems. This technique has been
used extensively in the present study group’s department to deter-
mine the percentage volume of liver metastases.31 Given previous
findings that HBO may divert the cell death pathway from necro-
sis to apoptosis, the quantification of both of these processes was
deemed essential. Serum bilirubin, ALT, ALP and GGT were also
measured as markers of liver injury at all endpoints in keeping
with standard practice. In this OLT model, hepatocyte injury
peaked at 12 h after reperfusion, as evidenced by maximum
necrosis, apoptosis and serum ALT levels, which then progres-
sively reduced. Serum bilirubin, ALP and GGT remained slightly
elevated in the first 24 h and demonstrated a rapid rise by 48 h.All
serum biochemistry had normalized by day 7. An interesting phe-
nomenon was the consistently higher severity of injury in the left
lobe of the liver. This effect may be associated with the fact that, in
the rat, the left lobe represents half of the total liver volume.
Alternatively, it may reflect unique hepatic blood supply or flow
characteristics. This finding reinforces the importance of assessing
several different areas within each liver when investigating IPRI in
the rat model, or consistently assessing the left lobe in order to
determine the maximum severity.
The application of HBO delivered in the post-OLT setting sig-
nificantly reduced the severity of IPRI. This was seen across all
liver lobes and was demonstrated by a major reduction in both
apoptosis and necrosis, along with improvements in serum bio-
chemistry. It is clear that HBO therapy acts by limiting the process
of IPRI, not simply by altering the cell death pathway, as both
necrosis and apoptosis were significantly reduced; these findings
support recent research focusing on HBO therapy as a molecular
switch that acts at the cellular level.21 In vitro studies recently
showed the ability of HBO to inhibit cell surface membrane-
bound guanidyl cyclase on neutrophils.32 Activation of this
enzyme is an essential prerequisite for neutrophil expression of
b-integrins, which play an integral and early role in the process of
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IPRI. It appears that HBO treatment leads to an increase in reac-
tive oxygen and reactive nitrogen species, which promotes the
excessive S-nitrosylation of b-actin.33 The high concentration of
myeloperoxidase in polymorphonucleocytes (PMN) is probably
the reason why this phenomenon is seen specifically in neutro-
phils and not in other leukocytes. This study group has prelimi-
nary data that suggest HBO therapy acts on PMNs in this model
by reducing the recruitment of PMNs within liver tissue.34 The
impact and mechanisms of action of HBO therapy on other non-
parenchymal cells remain to be investigated.
Emerging evidence also strongly suggests that HBO therapy
promotes liver regeneration in the presence of liver injury.
Therapy with HBO has been shown to stimulate hepatocyte pro-
liferation after liver resection in animal35,36 and, more recently,
human37 studies. The present study group has demonstrated that
hepatocyte proliferation may be used as a surrogate marker of
liver injury. Organs transplanted immediately demonstrated sig-
nificantly less necrosis and apoptosis and were associated with a
lower proliferation index. Organs transplanted after 24 h of pres-
ervation clearly showed more severe injury, as well as a resultant
increase in proliferation. The present study therefore aimed to
assess the cumulative effects of HBO therapy in minimizing IPRI
and thus reducing liver injury, and its capacity to stimulate pro-
liferation. Despite the significant reduction in liver injury pro-
duced by HBO therapy, hepatocyte proliferation was markedly
increased in HBO-treated liver at 48 h. However, by day 7, prolif-
eration had returned to normal in HBO-treated rat livers but
remained elevated in non-treated livers. This suggests that, as well
as reducing hepatocyte injury, HBO therapy may independently
promote liver regeneration; this latter finding may have important
clinical implications.
Although acute hepatocyte injury peaked at 12 h after OLT in
this model, ongoing liver injury is clear. This is evidenced by the
later rises in bilirubin, ALP and GGT levels. The ultrastructural
studies of the hepatic microvasculature performed at the single
time-point of 48 h after OLT further support this. Mean sinusoi-
dal diameter and sinusoidal density were both significantly
reduced compared with those in normal liver. Strong experimen-
tal evidence suggests the hepatic microcirculation is regulated by
endothelin-1 (ET-1) and NO. During ischaemia, an imbalance
occurs in these vasoactive substances as the focus of regulation
shifts towards ET-1, resulting in marked vasoconstriction of the
hepatic microcirculation.8,38 Therapy with HBO has been shown
to improve the microcirculation by a number of mechanisms.
These include the reduction of endothelial swelling and the inhi-
bition of PMN adhesion, both of which improve vascular diam-
eter.21,39 This study assessed changes in the microcirculatory
architecture at 48 h after OLT to determine persisting changes
following initial injury and found that sinusoidal diameter and
density remained significantly reduced in OLT liver compared
with normal liver. Treatment with HBO reversed this reduction to
normal levels and, similarly, transmission EM demonstrated
improvement in the cellular architecture of both hepatocytes and
liver sinusoidal endothelial cells after HBO therapy. Therefore,
HBO therapy appears to have persistent positive effects on both
parenchymal and non-parenchymal cells up to 48 h following
OLT.
This study clearly demonstrates that HBO therapy delivered in
the post-OLT period causes a significant reduction in IPRI sever-
ity. The present authors believe this to be the first study to dem-
onstrate such an effect using a true liver transplantation model
that includes sequential warm ischaemia, cold preservation and
warm reperfusion phases and thus closely resembles human OLT.
Treatment with HBO resulted in significant reductions in hepa-
tocyte necrosis and apoptosis and concurrently stimulated hepa-
tocyte proliferation and maintained a positive effect on the
microvascular and cellular architecture. These changes were dem-
onstrated despite the fact that HBO was delivered after the onset
of IPRI in the post-OLT period. This has significant clinical impli-
cations as this represents the most practical time-point to deliver
HBO.
The technical and logistic impediments to delivering HBO
therapy to critically ill patients have been largely overcome by the
introduction of large multi-chamber HBO units with easy access
and abundant internal facilities. Although multi-occupancy
chambers are now commonplace, treatmentmust be administered
by high-quality, fully trained teams of staff who are familiar with
the care and management of critically ill patients. The availability
of such facilities within specialty transplant centres could conceiv-
ably be readily achieved. Dose–response studies and investigations
into the outcomes of pre-OLT treatment of donor organs and
recipients, as well as into the mechanisms and specific effects of
HBO therapy on individual cell types in the liver, are required to
further characterize this therapeutic option. Experimental evi-
dence also supports the potential application of HBO in livers that
are small for size,36 live donor transplantation (donors and recipi-
ents),37 hepatic artery thrombosis,40 marginal donor organs and
acute liver failure.41 Results thus far are promising and may lead to
the consideration of HBO therapy for translation into routine
clinical practice in transplantation.
Acknowledgements
The authors wish to acknowledge Dr Brian Howden (Brian Howden Pty Ltd,
Melbourne, Victoria, Australia) for performing the orthotopic liver transplanta-
tions in this study, and Dr Paul Martinello (Department of Anatomical Pathol-
ogy, Austin Health, Melbourne, Vic, Australia) for his expertise in performing
and analysing tissues using transmission electron microscopy.
Conflicts of interest
None declared.
References
1. World Health Organization. (2004) The Global Burden of Disease. WHO
Health Statistics and Health Information Systems. Geneva: WHO.
2. Walia A, Schumann R. (2008) The evolution of liver transplantation prac-
tices. Curr Opin Organ Transplant 13:275–279.
112 HPB
HPB 2012, 14, 103–114 © 2011 International Hepato-Pancreato-Biliary Association
3. Malago M, Hertl M, Testa G, Rogiers X, Broelsch CE. (2002) Split-liver
transplantation: future use of scarce donor organs.World J Surg 26:275–
282.
4. Emre S. (2001) Living donor liver transplantation: a critical review. Trans-
plant Proc 33:3456–3457.
5. Azoulay D, Samuel D, Castaing D, Adam R, Adams D, Said G et al. (1999)
Domino liver transplants for metabolic disorders: experience with familial
amyloidotic polyneuropathy. J Am Coll Surg 189:584–593.
6. Bacchella T, Galvao FH, Jesus de Almeida JL, Figueira ER, de Moraes A,
Cesar Machado MC. (2008) Marginal grafts increase early mortality in
liver transplantation. Sao Paulo Med J 126:161–165.
7. Vollmar B, Glasz J, Leiderer R, Post S, Menger MD. (1994) Hepatic
microcirculatory perfusion failure is a determinant of liver dysfunction in
warm ischaemia–reperfusion. Am J Pathol 145:1421–1431.
8. Palmes D, Skawran S, Stratmann U, Armann B, Minin E, Herbst H et al.
(2005) Amelioration of microcirculatory damage by an endothelin A
receptor antagonist in a rat model of reversible acute liver failure. J
Hepatol 42:350–357.
9. Yamanouchi K, Eguchi S, Kamohara Y, Yanaga K, Okudaira S, Tajima Y
et al. (2007) Glycine reduces hepatic warm ischaemia–reperfusion injury
by suppressing inflammatory reactions in rats. Liver Int 27:1249–1254.
10. Jaeschke H, Farhood A, Bautista AP, Spolarics Z, Spitzer JJ, Smith CW.
(1993) Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18)
monoclonal antibody protects against ischaemia–reperfusion injury in rat
liver. Hepatology 17:915–923.
11. Shen XD, Ke B, Zhai Y, Gao F, Tsuchihashi S, Lassman CR et al. (2007)
Absence of toll-like receptor 4 (TLR4) signalling in the donor organ
reduces ischaemia and reperfusion injury in a murine liver transplantation
model. Liver Transpl 13:1435–1443.
12. Luntz SP, Unnebrink K, Seibert-Grafe M, Bunzendahl H, Kraus TW,
Buchler MW et al. (2005) HEGPOL: randomized, placebo-controlled, mul-
ticentre, double-blind clinical trial to investigate hepatoprotective effects
of glycine in the postoperative phase of liver transplantation. BMC Surg
5:18.
13. Kihara K, Ueno S, Sakoda M, Aikou T. (2005) Effects of hyperbaric
oxygen exposure on experimental hepatic ischaemia reperfusion injury:
relationship between its timing and neutrophil sequestration. Liver Transpl
11:1574–1580.
14. Howden BO, Jablonski P, Thomas AC, Walls K, Biguzas M, Marshall VC.
(1989) Rat liver preservation with UW solution. Transplant Proc 21:3797–
3798.
15. Spiegel HU, Palmes D. (1998) Surgical techniques of orthotopic rat liver
transplantation. J Invest Surg 11:83–96.
16. Tran NQ, Christophi C, Muralidharan V. (2008) Hyperbaric oxygen therapy
reduces ischaemia, preservation and reperfusion injury in liver transplan-
tation. Transplantation 86:416.
17. Tran NQ, Christophi C, Muralidharan V. (2008) Hyperbaric oxygen therapy
and ischaemia, preservation and reperfusion injury in liver transplanta-
tion. HPB 10:12.
18. Kuruppu D, Christophi C, O’Brien PE. (1997) Microvascular architecture
of hepatic metastases in a mouse model. HPB Surg 10:149–157; discus-
sion 158.
19. Cuthbertson CM, Su KH, Muralidharan V, Millar I, Malcontenti-Wilson C,
Christophi C. (2008) Hyperbaric oxygen improves capillary morphology in
severe acute pancreatitis. Pancreas 36:70–75.
20. Serracino-Inglott F, Habib NA, Mathie RT. (2001) Hepatic ischaemia–
reperfusion injury. Am J Surg 181:160–166.
21. Thom SR. (2004) Effects of hyperoxia on neutrophil adhesion. Undersea
Hyperb Med 31:123–131.
22. Frankenberg MV, Weimann J, Fritz S, Fiedler J, Mehrabi A, Buchler MW
et al. (2005) Gadolinium chloride-induced improvement of post-
ischaemic hepatic perfusion after warm ischaemia is associated with
reduced hepatic endothelin secretion. Transpl Int 18:429–436.
23. Frangogiannis NG. (2007) Chemokines in ischaemia and reperfusion.
Thromb Haemost 97:738–747.
24. Heijnen BH, Straatsburg IH, Padilla ND, Van Mierlo GJ, Hack CE, Van
Gulik TM. (2006) Inhibition of classical complement activation attenuates
liver ischaemia and reperfusion injury in a rat model. Clin Exp Immunol
143:15–23.
25. Buras JA, Stahl GL, Svoboda KK, Reenstra WR. (2000) Hyperbaric
oxygen downregulates ICAM-1 expression induced by hypoxia and
hypoglycaemia: the role of NOS. Am J Physiol Cell Physiol 278:292–302.
26. Larson JL, Stephenson LL, Zamboni WA. (2000) Effect of hyperbaric
oxygen on neutrophil CD18 expression. Plast Reconstr Surg 105:1375–
1381.
27. Martin JD, Thom SR. (2002) Vascular leukocyte sequestration in decom-
pression sickness and prophylactic hyperbaric oxygen therapy in rats.
Aviat Space Environ Med 73:565–569.
28. Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. (1995) Exposure
to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-
alpha) secretion from rat macrophages. Clin Exp Immunol 102:
655–659.
29. Lemasters JJ, Peng XX, Bachmann S, Currin RT, Gao W, Thurman RG.
(1995) Dual role of Kupffer cell activation and endothelial cell damage in
reperfusion injury to livers stored for transplantation surgery. J Gastro-
enterol Hepatol 10 (Suppl. 1):84–87.
30. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, Cejalvo D. (1993) Neutrophil
infiltration as an important factor in liver ischaemia and reperfusion injury.
Modulating effects of FK506 and cyclosporine. Transplantation 55:1265–
1272.
31. Kuruppu D, Christophi C, Bertram JF, O’Brien PE. (1996) Characteriza-
tion of an animal model of hepatic metastasis. J Gastroenterol Hepatol
11:26–32.
32. Thom SR. (2009) Oxidative stress is fundamental to hyperbaric oxygen
therapy. J Appl Physiol 106:988–995.
33. Thom SR, Bhopale VM, Mancini DJ, Milovanova TN. (2008) Actin
S-nitrosylation inhibits neutrophil beta2 integrin function. J Biol Chem
283:10822–10834.
34. Gin A, Tran NQ, Gan S, Muralidharan V, Christophi C. (2009) The effect of
hyperbaric oxygen therapy on ischaemia, preservation and reperfusion
injury after liver transplantation: impact on neutrophils and Kupffer cells.
Immunol Cell Biol 87:23–24.
35. Tolentino EC, Castro e Silva O, Zucoloto S, Souza ME, Gomes MC,
Sankarankutty AK et al. (2006) Effect of hyperbaric oxygen on liver regen-
eration in a rat model. Transplant Proc 38:1947–1952.
36. Mori H, Shinohara H, Arakawa Y, Kanemura H, Ikemoto T, Imura S et al.
(2007) Beneficial effects of hyperbaric oxygen pretreatment on massive
hepatectomy model in rats. Transplantation 84:1656–1661.
37. Suehiro T, Shimura T, Okamura K, Okada T, Okada K, Hashimoto S et al.
(2008) The effect of hyperbaric oxygen treatment on postoperative mor-
bidity of left lobe donor in living donor adult liver transplantation. Hepato-
gastroenterology 55:1014–1019.
38. Palmes D, Minin E, Budny T, Uhlmann D, Armann B, Stratmann U et al.
(2005) The endothelin/nitric oxide balance determines small-for-size liver
HPB 113
HPB 2012, 14, 103–114 © 2011 International Hepato-Pancreato-Biliary Association
injury after reduced-size rat liver transplantation. Virchows Arch 447:731–
741.
39. Hink J, Thom SR, Simonsen U, Rubin I, Jansen E. (2006) Vascular reac-
tivity and endothelial NOS activity in rat thoracic aorta during and after
hyperbaric oxygen exposure. Am J Physiol Heart Circ Physiol 291:1988–
1998.
40. Dubost T, Goubaux B, Duhalde M, Raucoules-Aime M, Wolkiewiez J,
Gugenheim J. (2002) Use of hyperbaric oxygen for hepatic artery throm-
bosis following adult orthotopic liver transplantation. Eur J Anaesthesiol
19:223–224.
41. Salhanick SD, Belikoff B, Orlow D, Holt D, Reenstra W, Buras JA. (2006)
Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-
1alpha expression. Acad Emerg Med 13:707–714.
Supporting information
Additional supporting information may be found in the online version of this
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Figure S1. Effects of hyperbaric oxygen therapy on normal liver. Normal liver
showed no evidence of necrosis.
Figure S2. Light microscopy of liver tissue sections from tissues collected at
48 h post-transplantation from normal liver, normal liver with hyperbaric
oxygen treatment, liver without preservation (immediate transplantation) with
ischaemia, preservation and reperfusion injury (IPRI), and liver with 24-h pres-
ervation with IPRI.
Figure S3. Light microscopy of liver tissue sections in ischaemia, preserva-
tion and reperfusion injury with and without hyperbaric oxygen treatment
investigated at 6 h, 12 h, 24 h and 48 h.
Figure S4. Comparison of the severity of injury in three liver lobes, according
to hepatocyte necrosis, apoptosis and proliferation, in hyperbaric oxygen-
treated and control livers at 12 h, 24 h and 48 h after transplantation.
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